AtriCure, Inc. Payments to Acquire Debt Securities, Available-for-sale
AtriCure, Inc. (ATRC) reported Payments to Acquire Debt Securities, Available-for-sale of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2025-02-14
- AtriCure, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2023-12-31 was $0.00.
- AtriCure, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- AtriCure, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- AtriCure, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2022-09-30 was $20.70M, a 68.53% decline year-over-year.
- AtriCure, Inc. payments to acquire debt securities, available-for-sale for fiscal 2024 was $0.00.
- AtriCure, Inc. payments to acquire debt securities, available-for-sale for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- AtriCure, Inc. payments to acquire debt securities, available-for-sale for fiscal 2022 was $24.64M, a 85.77% decline from fiscal 2021.
- AtriCure, Inc. payments to acquire debt securities, available-for-sale for fiscal 2021 was $173.10M, a 23.76% decline from fiscal 2020.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-14 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $0.00 derived: sum of 2 quarters · filed 2025-02-14 | $0.00 10-K · filed 2025-02-14 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-07-26 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $20.70M derived: sum of 2 quarters · filed 2025-02-14 | $24.64M 10-K · filed 2025-02-14 | |
| 2022-09-30 | $20.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $24.64M 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $3.94M 10-Q · filed 2023-07-26 | |||
| 2021-12-31 | $12.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $78.29M derived: sum of 2 quarters · filed 2024-02-16 | $173.10M 10-K · filed 2024-02-16 | |
| 2021-09-30 | $65.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $160.58M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $94.82M 10-Q · filed 2022-08-03 | |||
| 2020-12-31 | $26.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $227.04M 10-K · filed 2023-02-22 | ||
| 2020-09-30 | $200.79M 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $73.25M 10-K · filed 2022-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |